WinHealth Pharma ApS: Financial statements 2024
CVR: 43721682
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
WinHealth Pharma ApS (CVR 43721682) has filed annual accounts for 2024. In 2024, the company reported a gross profit of EUR -104,432 and a net result of EUR -105,652 compared with EUR -516,156 the year before. Equity in the 2024 report amounted to EUR -616,430.
- Gross Profit
- EUR -104,432
- Profit/Loss
- EUR -105,652
- Equity
- EUR -616,430
- Total Assets
- EUR 51,674
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -104K EUR | -106K EUR | -616K EUR | - |
| 2023 | - | -515K EUR | -516K EUR | -511K EUR | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
WinHealth Pharma ApS has published its annual report for 2023. Gross profit came to DKK -514,855, and the net result was DKK -516,156.
About WinHealth Pharma ApS
WinHealth Pharma ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company has been dissolved on 17 March 2026. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. In 2024, the company reported a gross profit of EUR -104,432 and a net result of EUR -105,652 compared with EUR -516,156 the year before. Equity in the 2024 report amounted to EUR -616,430.